【礼来(LLY.US)将在印度推出替尔泊肽注射笔,与诺和诺德(NVO.US)Wegovy同台竞技 】智通财经APP获悉

智通财经
26 Jun
【礼来(LLY.US)将在印度推出替尔泊肽注射笔,与诺和诺德(NVO.US)Wegovy同台竞技 】智通财经APP获悉,礼来公司(LLY.US)周四宣布,印度药品监管机构已批准其替尔泊肽(Mounjaro)预填充注射笔上市。这一举措将拓展礼来在日益增长的减肥药物市场中的产品选择,同时加剧与诺和诺德(NVO.US)近期推出的司美格鲁肽(Wegovy)之间的竞争。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10